James J Chamberlain1, Eric L Johnson2, Sandra Leal3, Andrew S Rhinehart4, Jay H Shubrook5, Lacie Peterson6. 1. St. Mark's Hospital and St. Mark's Diabetes Center, Salt Lake City, Utah (J.J.C.). 2. University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota (E.L.J.). 3. SinfoníaRx, Tucson, Arizona (S.L.). 4. Glytec, Marco Island, Florida (A.S.R.). 5. Touro University College of Osteopathic Medicine, Vallejo, California (J.H.S.). 6. Utah State University, Taylorsville, Utah (L.P.).
Abstract
Description: The American Diabetes Association (ADA) annually updates its Standards of Medical Care in Diabetes to provide clinicians, patients, researchers, payers, and other interested parties with evidence-based recommendations for the diagnosis and management of patients with diabetes. Methods: For the 2018 standards, the ADA Professional Practice Committee searched MEDLINE through November 2017 to add, clarify, or revise recommendations on the basis of new evidence. The committee rated the recommendations as A, B, or C depending on the quality of evidence or E for expert consensus or clinical experience. The standards were reviewed and approved by the Executive Committee of the ADA Board of Directors, which includes health care professionals, scientists, and laypersons. Feedback from the larger clinical community informed revisions. Recommendations: This synopsis focuses on guidance relating to cardiovascular disease and risk management in nonpregnant adults with diabetes. Recommendations address diagnosis and treatment of cardiovascular risk factors (hypertension and dyslipidemia), aspirin use, screening for and treatment of coronary heart disease, and lifestyle interventions.
Description: The American Diabetes Association (ADA) annually updates its Standards of Medical Care in Diabetes to provide clinicians, patients, researchers, payers, and other interested parties with evidence-based recommendations for the diagnosis and management of patients with diabetes. Methods: For the 2018 standards, the ADA Professional Practice Committee searched MEDLINE through November 2017 to add, clarify, or revise recommendations on the basis of new evidence. The committee rated the recommendations as A, B, or C depending on the quality of evidence or E for expert consensus or clinical experience. The standards were reviewed and approved by the Executive Committee of the ADA Board of Directors, which includes health care professionals, scientists, and laypersons. Feedback from the larger clinical community informed revisions. Recommendations: This synopsis focuses on guidance relating to cardiovascular disease and risk management in nonpregnant adults with diabetes. Recommendations address diagnosis and treatment of cardiovascular risk factors (hypertension and dyslipidemia), aspirin use, screening for and treatment of coronary heart disease, and lifestyle interventions.
Authors: Julie C Lauffenburger; Jennifer Lewey; Saira Jan; Sagar Makanji; Christina A Ferro; Alexis A Krumme; Jessica Lee; Roya Ghazinouri; Nancy Haff; Niteesh K Choudhry Journal: JAMA Netw Open Date: 2019-03-01
Authors: Janett A Hildebrand; John Billimek; Jung-Ah Lee; Dara H Sorkin; Ellen F Olshansky; Stephen L Clancy; Lorraine S Evangelista Journal: Patient Educ Couns Date: 2019-09-09